Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver

Anna Kotronen (Corresponding Author), Tuulikki Seppänen-Laakso, Jukka Westerbacka, Tuula Kiviluoto, Johanna T. Arola, Anna-Liisa Ruskeepää, Matej Orešič, Hannele Yki-Järvinen

Research output: Contribution to journalArticleScientificpeer-review

133 Citations (Scopus)

Abstract

OBJECTIVE—To determine whether 1) hepatic ceramide and diacylglycerol concentrations, 2) SCD1 activity, and 3) hepatic lipogenic index are increased in the human nonalcoholic fatty liver.

RESEARCH DESIGN AND METHODS—We studied 16 subjects with (n = 8) and without (n = 8) histologically determined nonalcoholic fatty liver (NAFL+ and NAFL) matched for age, sex, and BMI. Hepatic concentrations of lipids and fatty acids were quantitated using ultra-performance liquid chromatography coupled to mass spectrometry and gas chromatography.

RESULTS—The absolute (nmol/mg) hepatic concentrations of diacylglycerols but not ceramides were increased in the NAFL+ group compared with the NAFL group. The livers of the NAFL+ group contained proportionally less long-chain polyunsaturated fatty acids as compared with the NAFL group. Liver fat percent was positively related to hepatic stearoyl-CoA desaturase 1 (SCD1) activity index (r = 0.70, P = 0.003) and the hepatic lipogenic index (r = 0.54, P = 0.030). Hepatic SCD1 activity index was positively related to the concentrations of diacylglycerols (r = 0.71, P = 0.002) but not ceramides (r = 0.07, NS).

CONCLUSIONS—We conclude that diacylglycerols but not ceramides are increased in NAFL. The human fatty liver is also characterized by depletion of long polyunsaturated fatty acids in the liver and increases in hepatic SCD1 and lipogenic activities.

Original languageEnglish
Pages (from-to)203-208
Number of pages6
JournalDiabetes
Volume58
Issue number1
DOIs
Publication statusPublished - 2009
MoE publication typeA1 Journal article-refereed

    Fingerprint

Keywords

  • Non-alcoholic fatty liver disease
  • diacylglycerols
  • ceramides
  • SCD1
  • lipogenesis
  • long polyunsaturated fatty acids

Cite this